RemoteOmics

Trademark usage description

medical research; laboratory services; medical research laboratory services; biomedical research services; blood analysis services; blood analysis ser Read More

Classification Information

Class [042]
Medical research; laboratory services; medical research laboratory services; biomedical research services; blood analysis services; blood analysis services for scientific research purposes; biofluid analysis services; biofluid analysis services for scientific research purposes; providing temporary use of web-based applications for collecting, measuring, analysing, monitoring and reporting of health condition as well as physiological and biosignal data; consultancy relating to laboratory testing; rental of laboratory apparatus and instruments; information, consultancy and advisory services relating to all of the aforementioned services.

Classification kind code

Class [044]
Laboratory analysis services relating to the treatment of persons; blood test services; medical laboratory services for the analysis of blood and biofluid samples taken from patients; conducting screenings for disease risk factors; collection and preservation of human blood; providing medical information; preparation and processing of reports relating to health care and wellbeing (relating to health); providing medical information and health information to patients, consumers, and medical professionals by means of preparation of reports relating to health care matters; information, consultancy and advisory services relating to all of the aforementioned services.

Classification kind code

Mark Details

Serial Number

2379668

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 19^th Mar 2025	Agent Changed
Submitted for opposition 257 on 13^th Feb 2025	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 12^th Feb 2025	Created
Submitted for opposition 31 on 12^th Feb 2025	Formalized
Submitted for opposition 228 on 4^th Oct 2024	International Registration
Submitted for opposition 30 on 4^th Oct 2024	Filed